Effects of a Hypertension Management Mobile App on Urinary Sodium Excretion in Patients With Chronic Kidney Disease: Randomized Controlled Trial - PubMed
4 hours ago
- #chronic kidney disease
- #mobile health
- #hypertension
- A randomized controlled trial evaluated the effects of a hypertension management mobile app (CureApp HT) on urinary sodium excretion in patients with chronic kidney disease (CKD).
- The study included 101 CKD patients with hypertension and high urinary sodium excretion, divided into an intervention group (using the app plus lifestyle counseling) and a control group (lifestyle counseling alone).
- The app provided daily individualized guidance for salt restriction and supported self-monitoring, with a high engagement rate of 96%.
- Despite 76% of the intervention group reporting improved salt intake behaviors, there was no significant difference in urinary sodium excretion between groups after 12 weeks.
- Secondary outcomes, including blood pressure and other biomarkers, also showed no significant differences between groups.
- The study concluded that the app did not effectively reduce salt intake in CKD patients, suggesting a need for more intensive interventions to bridge the intention-behavior gap.